EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic Anticancer Activity of Annona muricata Leaf Extract and Cisplatin in 4T1 Triple-Negative Breast Cancer Cells

Oumayma Kouki, Mohamed Montassar Lasram, Amel Abidi, Jérôme Leprince iD, Imen Ghzaiel iD, John J Mackrill iD, Taoufik Ghrairi iD, Gérard Lizard iD, Olfa Masmoudi-Kouki iD

Cells · 2026

DOI: 10.3390/cells15030213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Oumayma Kouki und 8 weiteren Autor:innen. Beteiligte Einrichtung: LR18ES03, Laboratory of Neurophysiology, Cellular Physiopathology and Biomolecules Valorisation, Faculty of Science of Tunis, University Tunis El Man…. Hauptthemen laut MEDLINE: Cisplatin, Annona, Plant Extracts, Plant Leaves. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PHC-Utique, Horizon-Marie Skłodowska-Curie Actions (MSCA) RISE PsyCoMed Project, laboratory LR18ES03, the France–Tunisia CMCU-Campus PHC-Utique.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer remains one of the leading causes of cancer-related mortality among women worldwide. Although cisplatin is widely used in chemotherapy, its clinical efficacy is often limited by adverse effects and resistance. Thus, natural bioactive compounds are gaining attention as complementary therapeutic agents. This study aimed to evaluate the anti-tumor effects of Annona muricata leaf extract on murine breast cancer 4T1 cells, used alone or in combination with cisplatin. Cisplatin induced intrinsic apoptosis through mitochondrial membrane disruption, up-regulation of the Bax gene and inhibition of the PI3K/AKT/mTOR signaling pathway. Cisplatin also promoted hypoxia by HIF1α gene expression, inflammation by TNFα and IL-6 gene expression, and induced cell cycle arrest at the sub-G1 phase by down-regulation of cyclin D1 and cyclin E1 genes. Annona muricata leaf extract triggered autophagy-mediated 4T1 cell death through mainly mTOR down-regulation and increased expression of Beclin1 and LC3 genes. It also induced cell cycle arrest at sub-G1 and S phases in a concentration- and time-dependent manner. When, combined with cisplatin, Annona muricata extract shifts the cell death pathway from intrinsic apoptosis toward autophagy by reduced caspase-3 gene expression and activity and enhanced LC3-I to LC3-II conversion. Moreover, Annona muricata extract attenuated cisplatin-induced inflammation by inhibiting TNFα and IL-6 gene expression and reinforced cell cycle arrest through suppression of the cyclin D1 gene. In conclusion, our results suggest that Annona muricata leaf extract exerts significant anti-tumor activity in breast cancer cells and may enhance cisplatin efficacy by shifting the signaling pathway from intrinsic apoptosis toward autophagy, and attenuating inflammation-related effects, supporting its potential use as a complementary therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinAnnonaPlant ExtractsPlant LeavesTriple Negative Breast NeoplasmsAntineoplastic AgentsAnimalsFemaleApoptosisMiceCell Line, TumorAutophagyDrug SynergismSignal TransductionHumansTOR Serine-Threonine KinasesGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Annona muricata aqueous leaf extractapoptosisautophagycisplatinsynergetic anticancertriple-negative breast cancer cell line

Substanzen

CisplatinPlant ExtractsAntineoplastic AgentsTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • LR18ES03, Laboratory of Neurophysiology, Cellular Physiopathology and Biomolecules Valorisation, Faculty of Science of Tunis, University Tunis El Manar, Tunis 2092, Tunisia.
  • Laboratory of Neuroendocrine, Endocrine and Germinal Differentiation and Communication (NorDiC), Inserm UMR 1239, University Rouen Normandie, 76000 Rouen, France.
  • Clermont Auvergne National Polytechnic Institute, INP, French National Centre for Scientific Research, Institut Pascal, University Clermont Auvergne, 63001 Clermont-Ferrand, France.
  • Department of Physiology, University College Cork, Western Gateway Building, Western Road, T12 XF62 Cork, Ireland.
  • Laboratoire Interdisciplinaire Carnot de Bourgogne ICB UMR 6303 (Team Prof. N. Millot), French National Center for Scientific Research (CNRS), Inserm, University Bourgogne Europe, 21000 Dijon, France.

ORCID-Profile: Jérôme Leprince, Imen Ghzaiel, John J Mackrill, Taoufik Ghrairi, Gérard Lizard, Olfa Masmoudi-Kouki

Förderung

  • PHC-Utique
  • Horizon-Marie Skłodowska-Curie Actions (MSCA) RISE PsyCoMed Project
  • laboratory LR18ES03, the France–Tunisia CMCU-Campus PHC-Utique
  • France/PHC Utique
  • French Ministry of Europe and Foreign Affairs and the Tunisian Ministry of Higher Education and Scientific Research
  • University of Tunis El Manar and a France–Tunisia exchange program

Zitieren

APA

Kouki, O., Lasram, M. M., Abidi, A., Leprince, J., Ghzaiel, I., Mackrill, J. J., Ghrairi, T., Lizard, G., & Masmoudi-Kouki, O. (2026). Synergistic Anticancer Activity of Annona muricata Leaf Extract and Cisplatin in 4T1 Triple-Negative Breast Cancer Cells. Cells. https://doi.org/10.3390/cells15030213

Vancouver

Kouki O, Lasram MM, Abidi A, Leprince J, Ghzaiel I, Mackrill JJ, et al. Synergistic Anticancer Activity of Annona muricata Leaf Extract and Cisplatin in 4T1 Triple-Negative Breast Cancer Cells. Cells. 2026. doi:10.3390/cells15030213

BibTeX
@article{Kouki2026,
  author = {Kouki, Oumayma and Lasram, Mohamed Montassar and Abidi, Amel and Leprince, Jérôme and Ghzaiel, Imen and Mackrill, John J and Ghrairi, Taoufik and Lizard, Gérard and Masmoudi-Kouki, Olfa},
  title = {Synergistic Anticancer Activity of Annona muricata Leaf Extract and Cisplatin in 4T1 Triple-Negative Breast Cancer Cells},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15030213}
}
Kostenlos starten →